Glenmark Pharma Gets Tentative Nod From Usfda For Anticoagulant Drug

Glenmark Pharma Gets Tentative Nod From Usfda For Anticoagulant Drug

By, Admin 23 December 2020

Drug Major Glenmark Pharma On Monday Said It Has Received Tentative Approval From The Us Health Regulator For Anticoagulant Dabigatran Etexilate Capsules. The Approved Product Is A Generic Version Of Boehringer Ingelheim Pharmaceuticals' Pradaxa Capsules.Pradaxa Is Used To Prevent Blood Clots From Forming Because Of Certain Irregular Heart Rhythm.Glenmark Pharmaceuticals Has Been Granted Tentative Approval By The United States Food And Drug Administration (Usfda) For Dabigatran Etexilate Capsules In The Strengths Of 75 Mg, 110 Mg, And 150 Mg, The Company Said In A Regulatory Filing. Quoting Iqvia Sales Data For The 12 Month Period Ending August 2020, Glenmark Said Pradaxa Capsules, 75, 110 Mg And 150 Mg, Market Achieved Annual Sales Of Approximately Usd 550.9 Million.Glenmark Said Its Current Portfolio Consists Of 166 Products Authorised For Distribution In The Us Marketplace And 45 Abbreviated New Drug Applications Are Pending Approval With The Usfda.Shares Of The Company Were Trading 2.32 Per Cent Higher At Rs 528 Per Scrip On The Bse.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!